Tech Times of New York: Press Releases

$Genmab Announces Positive Phase 3 Results for Epcoritamab Plus Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma, Demonstrating Statistically Significant Improvement in Progression-Free Survival$

Jun. 29, 2026

Genmab Announces Positive Phase 3 Results for Epcoritamab Plus Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma, Demonstrating Statistically Significant Improvement in Progression-Free Survival

GlobeNewswire

Jun. 29, 2026

Dragon Pharma Store Announces Expansion of Research Product Catalog with Addition of KLOW 80mg

GlobeNewswire

Jun. 29, 2026

Digital Realty Announces Secondary Offering of Common Stock by Blackstone

GlobeNewswire

Jun. 29, 2026

UP Fintech Investor News: If You Have Suffered Losses in UP Fintech Holding Limited (NASDAQ: TIGR), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

GlobeNewswire

$Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative Colitis Patients and Strengthening the Phase 3 Maintenance Safety Database$

Jun. 29, 2026

Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative Colitis Patients and Strengthening the Phase 3 Maintenance Safety Database

GlobeNewswire

$Résultats positifs de la partie 2 de l’essai de maintenance ABTECT démontrant un bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les données de sécurité$

Jun. 29, 2026

Résultats positifs de la partie 2 de l’essai de maintenance ABTECT démontrant un bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les données de sécurité

GlobeNewswire

Jun. 29, 2026

American Coastal Insurance Corporation Announces the Completion of $14.4 Million in Common Stock Share Repurchases

GlobeNewswire

Jun. 29, 2026

Nasdaq to Hold Second Quarter 2026 Investor Conference Call

GlobeNewswire

Jun. 29, 2026

Gain Therapeutics Receives FDA Clearance of IND to Advance GT-02287 into Phase 2 Clinical Development for Parkinson’s Disease

GlobeNewswire

Digital Realty Announces Purchase of Blackstone Interest in Three Northern Virginia Data Centers

Jun. 29, 2026

Tech Times of New York: Press Releases

June 2026

July 2026

August 2026

Press releases published on June 29, 2026

Praxis Precision Medicines Announces Extension Period for Relutrigine for Treatment of SCN2A and SCN8A Developmental and Epileptic Encephalopathies

Mama’s Creations. Announces Proposed Public Offering of Common Stock

TMD Energy Limited Announces Financial Results for the Six Months Ended December 31, 2025

Beach Day API Launches Real-Time Beach and Ocean Data API for Developers

Pathfinder Bancorp, Inc. Declares Dividend

Elevra Lithium Breaks Ground on Fully Funded North American Lithium Expansion

Silo Pharma Advances SPC-15 PTSD Therapeutic with Drug-Device Robustness Study Ahead of Planned FDA Type C Meeting Request

NeoVolta to Participate in Virtual Fireside Chat Hosted by Needham & Company on June 30, 2026

Genmab Announces Positive Phase 3 Results for Epcoritamab Plus Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma, Demonstrating Statistically Significant Improvement in Progression-Free Survival

Dragon Pharma Store Announces Expansion of Research Product Catalog with Addition of KLOW 80mg

Digital Realty Announces Secondary Offering of Common Stock by Blackstone

UP Fintech Investor News: If You Have Suffered Losses in UP Fintech Holding Limited (NASDAQ: TIGR), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative Colitis Patients and Strengthening the Phase 3 Maintenance Safety Database

Résultats positifs de la partie 2 de l’essai de maintenance ABTECT démontrant un bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les données de sécurité

American Coastal Insurance Corporation Announces the Completion of $14.4 Million in Common Stock Share Repurchases

Nasdaq to Hold Second Quarter 2026 Investor Conference Call

Gain Therapeutics Receives FDA Clearance of IND to Advance GT-02287 into Phase 2 Clinical Development for Parkinson’s Disease

Digital Realty Announces Purchase of Blackstone Interest in Three Northern Virginia Data Centers

QuickBuzz Announces Strong Momentum Following Successful Presentation at the Global Family Investment Summit

Lakefront Receives Transparency Notification from Madison Avenue Partners

Advanced Search Options